Rheinmetall’s Confidence Crisis: A Leadership Question Overshadows Record Order Books

The numbers tell one story; the share price tells another. Rheinmetall’s order backlog has swelled past €80 billion, second-quarter revenue climbed 69 percent, and the company just handed over its first Lynx prototype to the US Army. Yet investors keep selling. The stock closed Friday at €1,036.00, down 3.2 percent on the day, extending a slide that has now erased roughly a third of the company’s value since January.

The disconnect has a name: Armin Papperger. The chief executive, once celebrated for steering Rheinmetall into a defence supercycle, now finds himself at the centre of a mounting credibility debate. Media reports have trained their focus on halted flagship programmes, delivery slippages, and a management structure widely seen as revolving too heavily around one individual.

A Summer of Setbacks

The trouble traces back to early July, when the defence ministry pulled the plug on the F126 frigate programme, a project where Rheinmetall served as lead contractor. The contract instead went to ThyssenKrupp Marine Systems for eight smaller MEKO A-200 frigates. The stock dropped as much as 8.5 percent in response. Weeks later, in August, the company was forced to trim its 2026 guidance, now projecting revenue of €13.7 billion to €14.2 billion with an operating margin around 19 percent.

That downward revision, announced on 6 August, triggered a broader reassessment that has yet to run its course. The sell-off has also dragged down peers including RENK, Hensoldt and TKMS, though Rheinmetall remains the sector’s most visible casualty.

Execution questions have piled up beyond the frigate cancellation. The Arminius project — a Boxer wheeled armoured vehicle programme with a fixed contract volume of roughly €12.4 billion plus a €2 billion service agreement — saw its first tranche ordered only at the end of 2026, later than originally scheduled. Two additional options could eventually lift the total framework to as much as €26 billion, but the delay has fed doubts about whether the company can deliver on its ambitious growth trajectory.

Even the drone business faces headwinds. An expected initial order worth nearly €1 billion through the Boeing Australia cooperation for a planned Luftwaffe combat drone now appears unlikely to materialise, with the Bundeswehr reportedly waiting on competing bids from Helsing and Airbus.

Good News, Bad Reaction

Perhaps most telling is how the market has greeted positive developments. In early September, American Rheinmetall delivered the first of eight Lynx XM30 prototypes to the US Army, while the LUNA NG unmanned reconnaissance system received provisional road approval from the Bundeswehr’s aviation office. The shares fell around 3 percent anyway.

A similar pattern emerged in mid-August, when the Bundeswehr placed an order worth more than €500 million for 149 mobile rescue stations. A brief uptick followed, but it failed to reverse the broader trend. Investors, it seems, are no longer rewarding individual contract wins — they want proof that Rheinmetall can execute large-scale projects on time and to specification.

The Numbers Beneath the Noise

The irony is that the underlying business remains robust. Second-quarter revenue climbed 69 percent to €3.289 billion, beating the company’s own forecast of more than 60 percent growth. Operating profit reached €562 million, up 115 percent year-on-year with a margin of 17.1 percent, landing roughly 20 percent above analyst consensus.

The order book, meanwhile, stands between €80 billion and €80.5 billion — a 44 percent increase, with 70 percent of that total comprising firm orders. The book-to-bill ratio exceeds three times. For the full year, Rheinmetall still expects organic growth of 28 to 31 percent, even after the guidance cut.

Should investors sell immediately? Or is it worth buying Rheinmetall?

Yet the market’s risk perception has shifted. JPMorgan’s David Perry downgraded the stock from “Overweight” to “Neutral” on 7 May, trimming his price target to €1,500. His rationale: while the second-quarter figures were strong, updated forecasts for order intake and capital expenditure point to lower revenues between 2027 and 2030 than previously anticipated.

Deutsche Bank Research reaffirmed its “Buy” recommendation with a €1,800 price target on 3 September — a call that barely registered with investors. A day earlier, mwb research upgraded the stock from “Sell” to “Hold” but left its price target at €1,050, citing a price-to-earnings ratio of 32 for 2026 and 12 for 2030.

Short Sellers Move In

The bearish sentiment has attracted professional sceptics. Capital Fund Management has built a net short position of 0.90 percent of Rheinmetall’s shares, according to disclosure data — a signal that some sophisticated market participants expect further downside.

Technical indicators paint a similarly cautious picture. The 14-day relative strength index sits at 35.8, suggesting the stock is oversold, while the share price trades roughly 26 percent below its 200-day moving average of €1,398.02. At current levels, the stock stands about 48 percent below the record high of €2,007.00 reached in October.

A Counterpoint from the Top

One notable development cuts against the prevailing gloom. Papperger, through his holding company ATP Holding, purchased shares worth approximately €12 million in three tranches during June — the most recent on 25 June at an average price of €954.62, near the current 52-week low of €902.50.

Those purchases predate the current debate over his leadership role and can be read as a vote of confidence in the company’s strategy. Whether they will be enough to dispel doubts about operational execution remains an open question.

The December Test

All eyes now turn to 9 December, when the Bundestag votes on the Arminius project. The Boxer order — worth €12.4 billion in fixed contract value, with options potentially expanding the total to €26 billion — represents a significant opportunity to restore investor confidence.

Whether a contract of that magnitude can break the negative spell is far from certain. The pattern of recent weeks suggests that even substantial positive catalysts have failed to move the needle. At the heart of the matter lies a more fundamental question: can Rheinmetall convince the market that its growth story is about more than order intake — that it can actually deliver?

The company’s own ambitions make the stakes clear. At last November’s Capital Markets Day, Rheinmetall outlined plans to quintuple revenue to around €50 billion by 2030, with an operating margin above 20 percent. The recent string of delays and cancellations has given investors reason to question whether that pace is realistic.

For now, the shares remain caught between solid fundamentals and mounting execution risk — a tension that has already produced significant volatility and shows little sign of resolving before the December vote.